Twice-yearly drug eases symptoms in chronic rhinosinusitis with polyps
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...
Medscape13d
Functional Nasolacrimal Duct Obstruction -- A Nonexistent Condition?
The term functional nasolacrimal duct obstruction (FNLDO; watering with patent drainage) is misleading as it implies occluded drainage and solely nasolacrimal duct pathology. 'Normal' tear ...
WebMD4y
Sinus Pressure in the Workplace
Sinus pressure is always a nuisance, but how do you cope when it interferes with work? It sends attorney Pete Chambers to the doctor's office at least four times a year. Because I get so busy, I ...
Clinical Advisor7d
FDA to Review Depemokimab for Asthma With Eosinophilic Phenotype, CRSwNP
The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...